Founder & Medical Director,
Napa Pain Institute;
Spine & Pain Center of Kaua’i;
Redwood Pain Institute
Chief Medical Officer,
the Alfred E. Mann Foundation
Eric J. Grigsby, MD, MBA, nationally-renowned pain care specialist and founder of Napa Pain Institute, has left an impact in his community—and around the world—through his work in pain management.
Dr. Grigsby’s interest in health care and community service began before medical school, as an undergraduate student at Brown University. While there, he volunteered with disabled children at the Boston Children’s Hospital department of orthopedic surgery. It was during this time that he formed a deep empathy for the extent of the pain and suffering endured by patients with chronic illness. At this time, chronic pain wasn’t well understood and there were too few ways to treat it. Dr. Grigsby committed himself to finding ways to address chronic pain and turned it into a lifelong mission to advocate for better pain care as a physician, an industry innovator, and a global health philanthropist.
This commitment to advancing the care options available to patients suffering from pain and chronic disease led Dr. Grigsby to seek the best training, leading him to the world-renowned Mayo Clinic, where he completed his residency and later taught, before moving to the University of California at Davis. At UC Davis, he established the university’s pain management program and began formalizing what would become the first set of safe prescribing guidelines for the California Medical Board. Along with his commitment to effective pain care, he had an equal and important commitment to the safety of his patients and in his community.
In the early 1990s, Dr. Grigsby established the Napa Pain Institute, which grew quickly into one of the busiest private practices in the nation, with a reputation for advancing interventional, non-opioid therapies.
Dr. Grigsby created the nonprofit HealthRoots Foundation, dedicated to improving global health through on-the-ground service and innovation. HealthRoots partners with UC Berkeley, Stanford, and other leaders to host the annual Bay Area Global Health Innovation Challenges; supporting students around the world with innovative solutions to global health needs.
Today, Dr. Grigsby remains active in the conversation around safe prescribing, serving on the Napa County Opioid Coalition, and working with hospital groups to improve their prescribing practices, ensuring the best care for every patient.
_______________
Sessions at Neurovations Events
- 2018 Legacy Lecture: Assuring the Best Care for Every patient, Every Day
- MILD for Severe Lumbar Canal Stenosis: Initial Prospective Data & Complications
- The Appropriate Utilization of Spinal Injections for Pain
- Intrathecal Therapy: Our Highest Challenges & Opportunities
- An Overview of Advanced Pain Management Options: SCS & Pain Pumps
- The Appropriate Utilization of Spinal Injections for Pain
2007 Business of Pain
- Effective Practice Management
- Vertebral Augmentation
_______________
Select Publications
- Deer, T., Krames, E. S., Hassenbusch, S. J., Burton, A., Caraway, D., Dupen, S., … & Levy, R. (2007). Polyanalgesic consensus conference 2007: recommendations for the management of pain by intrathecal (intraspinal) drug delivery: report of an interdisciplinary expert panel. Neuromodulation: Technology at the neural interface, 10(4), 300-328.
- Deer, T., Krames, E. S., Hassenbusch, S., Burton, A., Caraway, D., Dupen, S., … & Levy, R. (2008). Future directions for intrathecal pain management: a review and update from the interdisciplinary Polyanalgesic Consensus Conference 2007. Neuromodulation: Technology at the Neural Interface, 11(2), 92-97.
- Deer, T. R., Prager, J., Levy, R., Rathmell, J., Buchser, E., Burton, A., … & Erdek, M. (2012). Polyanalgesic Consensus Conference 2012: recommendations for the management of pain by intrathecal (intraspinal) drug delivery: report of an interdisciplinary expert panel. Neuromodulation: Technology at the Neural Interface, 15(5), 436-466.
- Deer, T. R., Levy, R., Prager, J., Buchser, E., Burton, A., Caraway, D., … & Grigsby, E. (2012). Polyanalgesic Consensus Conference—2012: recommendations to reduce morbidity and mortality in intrathecal drug delivery in the treatment of chronic pain. Neuromodulation: Technology at the Neural Interface, 15(5), 467-482.
- Deer, T. R., Prager, J., Levy, R., Burton, A., Buchser, E., Caraway, D., … & Grigsby, E. (2012). Polyanalgesic Consensus Conference—2012: recommendations on trialing for intrathecal (intraspinal) drug delivery: report of an interdisciplinary expert panel. Neuromodulation: Technology at the Neural Interface, 15(5), 420-435.
- Rauck, R., Coffey, R. J., Schultz, D. M., Wallace, M. S., Webster, L. R., McCarville, S. E., … & Page, L. M. (2013). Intrathecal gabapentin to treat chronic intractable noncancer pain. Anesthesiology: The Journal of the American Society of Anesthesiologists, 119(3), 675-686.
- Eisele Jr, J. H., Grigsby, E. J., & Dea, G. (1992). Clonazepam treatment of myoclonic contractions associated with high-dose opioids: case report. Pain, 49(2), 231-232.
- Deer, T. R., Grigsby, E., Weiner, R. L., Wilcosky, B., & Kramer, J. M. (2013). A prospective study of dorsal root ganglion stimulation for the relief of chronic pain. Neuromodulation: Technology at the Neural Interface, 16(1), 67-72.
- Deer, T., Krames, E. S., Hassenbusch, S., Burton, A., Caraway, D., Dupen, S., … & Levy, R. (2008). Management of Intrathecal Catheter‐Tip Inflammatory Masses: An Updated 2007 Consensus Statement From An Expert Panel. Neuromodulation: Technology at the Neural Interface, 11(2), 77-91.
- Burton, A. W., Deer, T. R., Wallace, M. S., Rauck, R. L., & Grigsby, E. (2010). Considerations and methodology for trialing ziconotide. Pain Physician, 13(1), 23-33.
- Deer, T. R., Levy, R. M., Kramer, J., Poree, L., Amirdelfan, K., Grigsby, E., … & Scowcroft, J. (2017). Dorsal root ganglion stimulation yielded higher treatment success rate for complex regional pain syndrome and causalgia at 3 and 12 months: a randomized comparative trial. Pain, 158(4), 669.
- Rauck, R., Coffey, R. J., Schultz, D. M., Wallace, M. S., Webster, L. R., McCarville, S. E., … & Page, L. M. (2013). Intrathecal gabapentin to treat chronic intractable noncancer pain. Anesthesiology: The Journal of the American Society of Anesthesiologists, 119(3), 675-686.
- Giberson, C. E., Barbosa, J., Brooks, E. S., McGlothlen, G. L., Grigsby, E. J., Kohut, J. J., … & Poree, L. R. (2014). Epidural hematomas after removal of percutaneous spinal cord stimulator trial leads: two case reports. Regional anesthesia and pain medicine, 39(1), 73-77.
- Deer, Timothy, et al. Management of intrathecal catheter‐tip inflammatory masses: an updated 2007 consensus statement from an expert panel. Neuromodulation: Technology at the Neural Interface 11.2 (2008): 77-91.
- Konrad, P. E., Huffman, J. M., Stearns, L. M., Plunkett, R. J., Grigsby, E. J., Stromberg, E. K., … & Weaver, T. W. (2016). Intrathecal drug delivery systems (IDDS): the implantable systems performance registry (ISPR). Neuromodulation: Technology at the Neural Interface, 19(8), 848-856.